Current Research Studies

A RANDOMIZED STUDY EVALUATING 2 DOSE REGIMENS OF DUPILUMAB IN CHILDREN ?6 MONTHS OF AGE WEIGHING ?5 TO <15 KG WITH ACTIVE EOSINOPHILIC ESOPHAGITIS

EoE Tots

Phase: III
Clinicaltrials.gov ID: NCT07112378

What is the goal of the study?

This is a multicenter, randomized, single-blind (parents/guardian/caregiver) study investigating the safety, tolerability, efficacy, pharmacokinetics, and immunogenicity of 2 dosing regimens of dupilumab (higher and lower exposure dose regimens) in pediatric participants aged ?6 months and weighing ?5 kg and <15 kg with active eoe.>

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Michael Pickens
Study Team Member: Danny Gagucas, [email protected]